tirzepatide news 2025 A major new study in the New England Journal of Medicine compares two powerful weight-loss drugs: (Zepbound, Mounjaro) and semaglutide (Wegovy, Ozempic). Both medications are GLP-1 Novel drugs are transforming obesity

Long-term Results : Clinical trials have shown that patients can lose up to 15-20% of their body weight over 68 weeks of treatment

Informed consent Not applicable

Swelling of the face, tongue, lips, or throat

Can people without diabetes take GLP-1 medications

The safety and effectiveness of SAXENDA have not been established in patients less than 12 years of age

Recalls & Warnings August 22, 2013 UK Warns Against a Weight Loss Supplement Still Available to Americans The British government has identified the "fat-burner" supplement "I Force Dexaprine XR" as an unlicensed medical product and is instructing its retailer to remove it from the market, according to a report published in NutraIngredients.com